nxpe3 Antibody

What is NXPE3 protein and what is its molecular structure?

NXPE3 (Neurexophilin and PC-esterase domain family member 3), also known as FAM55C or PLAC9, is a secreted protein belonging to the neurexophilin family of neuropeptide-like glycoproteins. The protein contains four distinct domains: a variable N-terminal domain, a highly conserved neurexophilin and PC-esterase (NXPE) central domain, a short linker region, and a cysteine-rich C-terminal domain . NXPE3 binds to alpha neurexins, which are presynaptic transmembrane receptors promoting adhesion between dendrites and axons . The theoretical molecular weight of NXPE3 is approximately 24 kDa, but it typically appears at around 90 kDa in Western blot analysis, likely due to post-translational modifications and/or glycosylation .

What applications are NXPE3 antibodies typically used for?

NXPE3 antibodies have been validated for multiple research applications, providing researchers with versatile tools for protein detection. These applications include:

These applications allow researchers to detect NXPE3 in various experimental contexts, from protein quantification to localization studies . When selecting an application, consideration should be given to the specific research question, sample type, and required sensitivity.

How should NXPE3 antibodies be stored and handled for optimal performance?

Proper storage and handling of NXPE3 antibodies are crucial for maintaining their functionality and specificity. Most commercially available NXPE3 antibodies are provided in lyophilized form and require reconstitution before use . The recommended storage and handling protocol includes:

• Storage of lyophilized antibody at -20°C until ready to use

• Reconstitution in 100 μl of sterile distilled H2O with 50% glycerol or according to manufacturer's instructions

• After reconstitution, storage at 4°C for short-term use (approximately one month)

• For long-term storage, aliquoting and freezing at -20°C for up to six months

• Avoiding repeated freeze/thaw cycles to prevent antibody degradation

Following these guidelines will help ensure consistent antibody performance across experiments and maximize the shelf-life of the reagent.

What criteria should guide NXPE3 antibody selection for specific research applications?

When selecting an NXPE3 antibody, researchers should consider several key factors to ensure experimental success:

• Antibody Format: Determine whether polyclonal or monoclonal antibodies are most appropriate for your application. Currently, most commercial NXPE3 antibodies are rabbit polyclonal antibodies .

• Species Reactivity: Confirm the antibody's reactivity with your species of interest. Available NXPE3 antibodies primarily react with human NXPE3, with some predicted to cross-react with mouse and rat NXPE3 .

• Application Compatibility: Verify that the antibody has been validated for your specific application. Most NXPE3 antibodies are tested for ELISA, WB, IHC, ICC, IF, and flow cytometry .

• Epitope Information: Consider the immunogen used to generate the antibody. For example, some antibodies target recombinant fragments corresponding to specific amino acid sequences (e.g., 115-290 AA of human FAM55C) , while others target broader regions (e.g., Q29-D499) .

• Validation Data: Review available validation data, including Western blot images, immunofluorescence results, and flow cytometry profiles, to assess antibody performance .

This systematic approach to antibody selection will help ensure reliable and reproducible experimental results.

Why does NXPE3 appear at approximately 90 kDa in Western blots despite a calculated molecular weight of 24 kDa?

The discrepancy between NXPE3's calculated molecular weight (approximately 24 kDa) and its observed molecular weight (approximately 90 kDa) in Western blot analysis represents a common phenomenon in protein research . This discrepancy can be explained by several factors:

• Post-translational Modifications: NXPE3 likely undergoes extensive post-translational modifications, particularly glycosylation, which can substantially increase its apparent molecular weight.

• Protein Structure: The cysteine-rich C-terminal domain of NXPE3 may form disulfide bridges that alter protein migration patterns in SDS-PAGE.

• Alternative Splicing: As noted in the literature, "Alternative splicing results in multiple transcript variants" , which could contribute to unexpected molecular weights.

• Dimerization/Multimerization: Some proteins form stable dimers or multimers that are not fully dissociated under standard SDS-PAGE conditions.

When analyzing Western blot results, researchers should account for this discrepancy and use appropriate positive controls to confirm the identity of NXPE3 bands. Validation using multiple antibodies targeting different epitopes can provide additional confirmation.

What approaches should be used to validate NXPE3 antibody specificity?

Thorough validation of NXPE3 antibody specificity is essential for generating reliable research data. A comprehensive validation strategy should include:

• Western Blot Analysis: Confirm the antibody detects a band of the expected size (~90 kDa) in relevant cell lysates. Validation data shows detection in A549, U251, and THP-1 cell lines .

• Blocking Peptide Experiments: Use the immunizing peptide to competitively inhibit antibody binding, demonstrating specificity.

• Knockout/Knockdown Controls: Test the antibody in samples where NXPE3 has been knocked out or knocked down to confirm the absence of signal.

• Cross-Reactivity Assessment: Evaluate potential cross-reactivity with related proteins, particularly other NXPE family members. Available data indicates "No cross-reactivity with other proteins" .

• Multiple Detection Methods: Validate the antibody using complementary techniques (e.g., IF, ICC, flow cytometry) to confirm consistent target recognition across platforms .

• Statistical Design Considerations: Apply robust experimental design principles as discussed in antibody microarray literature, including appropriate controls and normalization procedures to eliminate systematic bias .

Implementing these validation steps will enhance confidence in experimental results and facilitate accurate interpretation of data.

What are the recommended protocols for Western blot detection of NXPE3?

Optimized Western blot protocols for NXPE3 detection should account for the protein's characteristics and antibody properties. Based on available validation data, the following protocol is recommended:

• Sample Preparation:

  • Use whole cell lysates from relevant cell types (e.g., A549, U251, THP-1)

  • Load approximately 30 μg of protein per lane under reducing conditions

• Gel Electrophoresis:

  • Use 5-20% gradient SDS-PAGE gels for optimal resolution

  • Run at 70V (stacking gel) followed by 90V (resolving gel) for 2-3 hours

• Protein Transfer:

  • Transfer to nitrocellulose membrane at 150 mA for 50-90 minutes

• Blocking:

  • Block with 5% non-fat milk in TBS for 1.5 hours at room temperature

• Primary Antibody Incubation:

  • Dilute NXPE3 antibody to 0.5-2 μg/mL (approximately 1:500 to 1:2000 dilution)

  • Incubate overnight at 4°C

• Washing:

  • Wash with TBS-0.1% Tween, 3 times for 5 minutes each

• Secondary Antibody Incubation:

  • Use anti-rabbit IgG-HRP at 1:5000 dilution

  • Incubate for 1.5 hours at room temperature

• Detection:

  • Develop using enhanced chemiluminescence (ECL) detection system

  • Expect to observe a band at approximately 90 kDa

This protocol has been demonstrated to produce specific detection of NXPE3 in human cell lysates with minimal background interference.

How can immunofluorescence experiments with NXPE3 antibodies be optimized?

Immunofluorescence and immunocytochemistry techniques using NXPE3 antibodies require specific optimization to achieve clear cellular localization with minimal background. Based on established protocols, the following approach is recommended:

• Cell Preparation:

  • Culture appropriate cell lines (e.g., U2OS cells) on coverslips or in chamber slides

  • Fix cells using paraformaldehyde (typically 4%)

• Antigen Retrieval:

  • For optimal epitope accessibility, perform enzyme antigen retrieval for approximately 15 minutes

• Blocking:

  • Block with 10% goat serum to reduce non-specific binding

  • Blocking time and temperature should be optimized for each cell type

• Primary Antibody Incubation:

  • Use NXPE3 antibody at 5 μg/mL concentration

  • Incubate overnight at 4°C for optimal binding

• Secondary Antibody:

  • Use fluorophore-conjugated anti-rabbit IgG (e.g., DyLight®488) at 1:500 dilution

  • Incubate for 30 minutes at 37°C

• Nuclear Counterstaining:

  • Include DAPI or similar nuclear stain for proper cellular context

  • Mount with anti-fade mounting medium to preserve fluorescence

• Imaging:

  • Use appropriate filter sets for the selected fluorophore

  • Capture multiple fields to ensure representative results

This protocol enables visualization of NXPE3 in its cellular context. Given that NXPE3 is described as a secreted protein , researchers should pay particular attention to membrane and extracellular localization patterns.

What are the critical parameters for flow cytometry analysis using NXPE3 antibodies?

Flow cytometry using NXPE3 antibodies requires careful optimization of several parameters to generate meaningful data. The following protocol incorporates best practices from validation studies:

• Cell Preparation:

  • Harvest cells (e.g., THP-1) in single-cell suspension

  • Fix cells with 4% paraformaldehyde to preserve cellular structures

  • Use approximately 1×10^6 cells per sample

• Blocking:

  • Block with 10% normal goat serum to reduce non-specific binding

  • Blocking time should be optimized based on cell type

• Primary Antibody Staining:

  • Use 1 μg of NXPE3 antibody per 1×10^6 cells

  • Incubate for 30 minutes at 20°C

• Secondary Antibody Staining:

  • Use fluorophore-conjugated secondary antibody (e.g., DyLight®488) at 5-10 μg per 1×10^6 cells

  • Incubate for 30 minutes at 20°C

• Controls:

  • Include isotype control (e.g., rabbit IgG at 1 μg per 1×10^6 cells)

  • Include unlabeled sample as additional control

  • Consider including positive control samples when available

• Data Analysis:

  • Generate overlay histograms comparing test sample, isotype control, and unlabeled sample

  • Quantify percentage of positive cells and mean fluorescence intensity

This protocol has been successfully used to detect NXPE3 in THP-1 cells and can be adapted for other cell types of interest .

How can high background issues in NXPE3 immunodetection be resolved?

High background is a common challenge in immunodetection experiments involving NXPE3. Several strategies can be implemented to improve signal-to-noise ratio:

• Antibody Concentration Optimization:

  • Titrate primary antibody concentrations (starting from manufacturer recommendations)

  • For Western blot, test dilutions ranging from 1:500 to 1:2000

  • For immunofluorescence, test concentrations around 5 μg/mL

• Blocking Protocol Enhancement:

  • Extend blocking time (up to 2 hours at room temperature)

  • Test alternative blocking reagents (BSA, normal serum, commercial blockers)

  • Consider adding 0.1-0.3% Triton X-100 to blocking buffer for intracellular targets

• Washing Optimization:

  • Increase number of washes (5-6 times instead of standard 3)

  • Extend wash durations (10 minutes per wash)

  • Use TBS-Tween (0.1%) for more stringent washing

• Secondary Antibody Considerations:

  • Use highly cross-adsorbed secondary antibodies

  • Optimize secondary antibody dilution (typically 1:5000 for WB , 1:500 for IF )

  • Ensure secondary antibody is compatible with host species of primary antibody

• Sample Quality Control:

  • Use fresh samples and reagents

  • Include protease inhibitors in lysis buffers

  • Avoid repeated freeze-thaw cycles of samples

These optimizations should be methodically tested and documented to establish the optimal protocol for specific experimental conditions.

What approaches can resolve inconsistent banding patterns in NXPE3 Western blots?

Inconsistent banding patterns in NXPE3 Western blots can arise from various factors, including protein degradation, alternative splicing, and sample preparation issues. To address these challenges:

• Sample Preparation Refinement:

  • Include protease inhibitor cocktail in lysis buffer

  • Maintain consistent protein concentration across samples (30 μg recommended)

  • Use optimized reducing conditions to ensure consistent protein denaturation

  • Maintain samples at 4°C during preparation

• Protein Size Discrepancy Analysis:

  • Be aware that NXPE3 runs at approximately 90 kDa despite a calculated weight of 24 kDa

  • Additional bands may represent alternatively spliced variants or degradation products

  • Compare observed banding patterns with validation data from manufacturers

• Gel System Optimization:

  • Use gradient gels (5-20% SDS-PAGE) for optimal resolution

  • Ensure consistent voltage during electrophoresis (70V stacking, 90V resolving)

  • Consider using pre-cast commercial gels for greater consistency

• Antibody Validation:

  • Test alternative NXPE3 antibodies targeting different epitopes

  • Compare results with published literature and manufacturer validation data

  • Consider using recombinant NXPE3 as a positive control

• Normalization and Statistical Analysis:

  • Apply appropriate normalization procedures to eliminate systematic bias

  • Use statistical methods developed for protein arrays to assess differential expression

Systematic troubleshooting using these approaches should help resolve inconsistent banding patterns and improve reproducibility.

How can specificity issues in NXPE3 immunofluorescence be addressed?

Achieving high specificity in NXPE3 immunofluorescence requires careful optimization of experimental conditions. The following strategies can help minimize non-specific staining:

• Antibody Validation for IF Applications:

  • Confirm the antibody is validated specifically for immunofluorescence

  • Review manufacturer's IF validation images for expected staining patterns

  • Consider testing multiple antibodies targeting different NXPE3 epitopes

• Fixation Method Optimization:

  • Test different fixation methods (4% PFA, methanol, acetone)

  • Optimize fixation duration (typically 10-20 minutes)

  • Consider gentle fixation methods that preserve epitope accessibility

• Antigen Retrieval Enhancement:

  • Implement enzyme antigen retrieval as used in validation protocols

  • Optimize retrieval time (15 minutes recommended)

  • Consider alternative retrieval methods (heat-induced epitope retrieval)

• Blocking and Permeabilization Refinement:

  • Use 10% goat serum as recommended in validation protocols

  • Optimize permeabilization conditions for intracellular targets

  • Consider adding 1-2% BSA to blocking solution to reduce background

• Controls Implementation:

  • Include secondary-only controls to assess non-specific binding

  • Include isotype controls at matching concentrations

  • Consider peptide competition controls when available

• Image Acquisition Optimization:

  • Use consistent exposure settings across samples

  • Implement background subtraction during image analysis

  • Acquire z-stacks for improved signal localization

These approaches, when systematically applied, should significantly improve the specificity of NXPE3 immunofluorescence staining.

How can NXPE3 antibodies be utilized in studying protein-protein interactions?

NXPE3 antibodies can be valuable tools for investigating protein-protein interactions, particularly with alpha neurexins, which are known binding partners . Advanced methodologies include:

• Co-Immunoprecipitation (Co-IP):

  • Use NXPE3 antibodies to immunoprecipitate protein complexes

  • Optimize lysis conditions to preserve protein-protein interactions

  • Use gentle elution methods to maintain complex integrity

  • Analyze precipitated complexes by Western blot or mass spectrometry

  • Consider crosslinking approaches for transient interactions

• Proximity Ligation Assay (PLA):

  • Combine NXPE3 antibodies with antibodies against potential binding partners

  • Optimize antibody concentrations and incubation conditions

  • Use species-specific PLA probes compatible with primary antibodies

  • Quantify interaction signals using appropriate imaging and analysis software

• Bioluminescence Resonance Energy Transfer (BRET):

  • Use NXPE3 antibodies to validate BRET results

  • Employ antibodies in parallel experiments to confirm protein expression

  • Correlate BRET signals with antibody-based detection methods

• Pull-down Assays with Recombinant Proteins:

  • Use antibodies to detect NXPE3 in pull-down experiments

  • Verify recombinant protein quality using NXPE3 antibodies

  • Assess binding specificity through competition experiments

These methodologies can provide valuable insights into NXPE3's interactions with neurexins and potentially other binding partners, advancing our understanding of its neurobiological functions.

What considerations are important when studying NXPE3 secretion and trafficking?

As NXPE3 is described as a secreted protein , studying its secretion and trafficking pathways requires specific experimental approaches:

• Cellular Fractionation:

  • Separate cellular compartments (membrane, cytosol, nucleus, secretory vesicles)

  • Use NXPE3 antibodies to track protein distribution across fractions

  • Include markers for different cellular compartments as controls

  • Optimize lysis conditions to preserve membrane-associated proteins

• Secretion Assays:

  • Collect conditioned media from cells expressing NXPE3

  • Concentrate secreted proteins using appropriate methods

  • Detect NXPE3 in media using validated antibodies

  • Compare intracellular and secreted pools under various conditions

• Live-Cell Imaging:

  • Use fluorescently labeled NXPE3 antibodies for surface labeling

  • Combine with markers of secretory pathway compartments

  • Implement pulse-chase experiments to track NXPE3 trafficking

  • Optimize imaging parameters for detection of secretory vesicles

• Inhibitor Studies:

  • Apply secretory pathway inhibitors (Brefeldin A, Monensin)

  • Use NXPE3 antibodies to assess changes in localization and secretion

  • Correlate inhibitor effects with functional outcomes

  • Include appropriate controls for inhibitor specificity

• Glycosylation Analysis:

  • Treat samples with glycosidases to assess NXPE3 modification

  • Use Western blotting with NXPE3 antibodies to detect mobility shifts

  • Correlate glycosylation patterns with secretion efficiency

  • Compare glycosylation across different cell types

These approaches can provide insights into the regulatory mechanisms controlling NXPE3 secretion and its potential roles in intercellular communication.

How can quantitative analysis of NXPE3 expression be optimized across different experimental platforms?

Accurate quantification of NXPE3 expression requires platform-specific optimization and appropriate statistical analysis:

• Western Blot Quantification:

  • Use housekeeping proteins (β-actin, GAPDH) for normalization

  • Implement standard curves using recombinant NXPE3 when possible

  • Ensure detection within the linear range of the assay

  • Apply statistical methods developed for protein microarrays

  • Use digital image analysis software for densitometry

• ELISA Development:

  • Optimize antibody pairs for sandwich ELISA

  • Establish standard curves using recombinant NXPE3

  • Validate assay parameters (sensitivity, specificity, reproducibility)

  • Consider high dilutions (1:20,000 - 1:80,000) for detection antibodies

  • Implement appropriate normalization and statistical analysis

• Flow Cytometry Quantification:

  • Use quantitative beads to establish standard curves

  • Optimize antibody concentration (1 μg per 1×10^6 cells recommended)

  • Compare mean fluorescence intensity across samples

  • Implement appropriate gating strategies based on controls

  • Use statistical methods appropriate for flow cytometry data

• Immunofluorescence Quantification:

  • Standardize image acquisition parameters

  • Use automated image analysis for unbiased quantification

  • Implement intensity-based and object-based measurements

  • Normalize to cell number or area

  • Apply statistical methods that account for cell-to-cell variability

• Multiplexed Analysis:

  • Consider antibody microarray approaches for parallel protein analysis

  • Implement experimental designs and normalization procedures as described in literature

  • Utilize statistical methods developed specifically for antibody microarrays

  • Validate findings across multiple platforms

These quantitative approaches, when properly optimized and statistically analyzed, can provide robust measurements of NXPE3 expression across experimental platforms, facilitating comparative studies and enhancing reproducibility.